Predicting market correction in first quarter of this year, We got over the January 1 fiscal cliff and are now staring into the face of hitting the debt ceiling in two more months. Take your profits and run to the exits.
Sentiment: Strong Sell
he thinks it's all thumbs up for him here on,LMAO.
Sentiment: Strong Sell
It's now early March, Pfizer still below $28. Market correction soon as the big boys decide to head for the exits. Strong sell. PFE back to $20 range by end of year.
thumbs up you know where?and he loves it,LOL.
Sentiment: Strong Sell
When you osted that PFE wouldn't hit $30 on Jan. 8, the stock closed at $26.02. Now less than two months later it is at $27.60 or 40% of the way to $30 from where it was back then.
I would remind you of the nearly-infallible 23.7% minimum annual closing range that has worked WITHOUT EXCEPTION for at leat least the last 31 years. It's pretty hard to go against something that has worked 31 times in the last 31 years but that's what we have here. If $25.85 continues as the 2013 closing low, we should see $32 before the year is out. And even if the closing low for the year is barely over $24, the odds would very heavily favor seeing at least one $30 close.
You have been con sistently wrong about how high PFE will go and you are almost certainly wrong yet again now. Nostradamus you are not.
Sentiment: Buy
You're all wet.
With div. of 3.7% and Eliquis approval with BMY and their strong pipeline I woudn't bet against $30 by end of year.AIMHO.
Sentiment: Hold